Body and Mind Inc.
BMMJ · OTC
4/30/2024 | 1/31/2024 | 10/31/2023 | 7/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -2.13 | 0.04 | -0.44 | -0.00 |
| FCF Yield | -10.74% | 1.51% | -11.68% | -17.82% |
| EV / EBITDA | -20.80 | -42.28 | -25.54 | -2.77 |
| Quality | ||||
| ROIC | -21.06% | -17.73% | -3.16% | -15.17% |
| Gross Margin | 44.58% | 45.66% | 37.40% | 311.40% |
| Cash Conversion Ratio | 0.53 | -0.14 | 0.30 | 0.18 |
| Growth | ||||
| Revenue 3-Year CAGR | -22.34% | -22.15% | -14.80% | -8.51% |
| Free Cash Flow Growth | -803.33% | 116.01% | 38.19% | -177.75% |
| Safety | ||||
| Net Debt / EBITDA | -10.14 | -19.56 | -14.22 | -1.74 |
| Interest Coverage | -8.72 | -4.01 | -0.63 | -5.38 |
| Efficiency | ||||
| Inventory Turnover | 3.86 | 3.76 | 1.62 | 0.06 |
| Cash Conversion Cycle | -56.33 | -83.52 | -9.10 | -1,489.66 |